Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Immunoassay
1.2.3 Genomic and WGS Role
1.2.4 rRT-PCR
1.3 Market by Application
1.3.1 Global Covid-19 Diagnostic Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Laboratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Diagnostic Market Perspective (2018-2033)
2.2 Covid-19 Diagnostic Growth Trends by Region
2.2.1 Global Covid-19 Diagnostic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Covid-19 Diagnostic Historic Market Size by Region (2018-2023)
2.2.3 Covid-19 Diagnostic Forecasted Market Size by Region (2024-2033)
2.3 Covid-19 Diagnostic Market Dynamics
2.3.1 Covid-19 Diagnostic Industry Trends
2.3.2 Covid-19 Diagnostic Market Drivers
2.3.3 Covid-19 Diagnostic Market Challenges
2.3.4 Covid-19 Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Diagnostic Players by Revenue
3.1.1 Global Top Covid-19 Diagnostic Players by Revenue (2018-2023)
3.1.2 Global Covid-19 Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Covid-19 Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Diagnostic Revenue
3.4 Global Covid-19 Diagnostic Market Concentration Ratio
3.4.1 Global Covid-19 Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Diagnostic Revenue in 2022
3.5 Covid-19 Diagnostic Key Players Head office and Area Served
3.6 Key Players Covid-19 Diagnostic Product Solution and Service
3.7 Date of Enter into Covid-19 Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Diagnostic Breakdown Data by Type
4.1 Global Covid-19 Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global Covid-19 Diagnostic Forecasted Market Size by Type (2024-2033)
5 Covid-19 Diagnostic Breakdown Data by Application
5.1 Global Covid-19 Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global Covid-19 Diagnostic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Covid-19 Diagnostic Market Size (2018-2033)
6.2 North America Covid-19 Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Covid-19 Diagnostic Market Size by Country (2018-2023)
6.4 North America Covid-19 Diagnostic Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Covid-19 Diagnostic Market Size (2018-2033)
7.2 Europe Covid-19 Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Covid-19 Diagnostic Market Size by Country (2018-2023)
7.4 Europe Covid-19 Diagnostic Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Diagnostic Market Size (2018-2033)
8.2 Asia-Pacific Covid-19 Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Covid-19 Diagnostic Market Size by Region (2018-2023)
8.4 Asia-Pacific Covid-19 Diagnostic Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Covid-19 Diagnostic Market Size (2018-2033)
9.2 Latin America Covid-19 Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Covid-19 Diagnostic Market Size by Country (2018-2023)
9.4 Latin America Covid-19 Diagnostic Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Diagnostic Market Size (2018-2033)
10.2 Middle East & Africa Covid-19 Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Covid-19 Diagnostic Market Size by Country (2018-2023)
10.4 Middle East & Africa Covid-19 Diagnostic Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Detail
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Covid-19 Diagnostic Introduction
11.1.4 Abbott Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023)
11.1.5 Abbott Diagnostics Recent Development
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Detail
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Covid-19 Diagnostic Introduction
11.2.4 Accelerate Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023)
11.2.5 Accelerate Diagnostics Recent Development
11.3 Ador Diagnostics
11.3.1 Ador Diagnostics Company Detail
11.3.2 Ador Diagnostics Business Overview
11.3.3 Ador Diagnostics Covid-19 Diagnostic Introduction
11.3.4 Ador Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023)
11.3.5 Ador Diagnostics Recent Development
11.4 Akkoni Biosystems
11.4.1 Akkoni Biosystems Company Detail
11.4.2 Akkoni Biosystems Business Overview
11.4.3 Akkoni Biosystems Covid-19 Diagnostic Introduction
11.4.4 Akkoni Biosystems Revenue in Covid-19 Diagnostic Business (2018-2023)
11.4.5 Akkoni Biosystems Recent Development
11.5 Alveo Technologies
11.5.1 Alveo Technologies Company Detail
11.5.2 Alveo Technologies Business Overview
11.5.3 Alveo Technologies Covid-19 Diagnostic Introduction
11.5.4 Alveo Technologies Revenue in Covid-19 Diagnostic Business (2018-2023)
11.5.5 Alveo Technologies Recent Development
11.6 Applied BioCode
11.6.1 Applied BioCode Company Detail
11.6.2 Applied BioCode Business Overview
11.6.3 Applied BioCode Covid-19 Diagnostic Introduction
11.6.4 Applied BioCode Revenue in Covid-19 Diagnostic Business (2018-2023)
11.6.5 Applied BioCode Recent Development
11.7 Aus Diagnostics
11.7.1 Aus Diagnostics Company Detail
11.7.2 Aus Diagnostics Business Overview
11.7.3 Aus Diagnostics Covid-19 Diagnostic Introduction
11.7.4 Aus Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023)
11.7.5 Aus Diagnostics Recent Development
11.8 BD Diagnostics
11.8.1 BD Diagnostics Company Detail
11.8.2 BD Diagnostics Business Overview
11.8.3 BD Diagnostics Covid-19 Diagnostic Introduction
11.8.4 BD Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023)
11.8.5 BD Diagnostics Recent Development
11.9 Biocartis
11.9.1 Biocartis Company Detail
11.9.2 Biocartis Business Overview
11.9.3 Biocartis Covid-19 Diagnostic Introduction
11.9.4 Biocartis Revenue in Covid-19 Diagnostic Business (2018-2023)
11.9.5 Biocartis Recent Development
11.10 BioFire Diagnostics
11.10.1 BioFire Diagnostics Company Detail
11.10.2 BioFire Diagnostics Business Overview
11.10.3 BioFire Diagnostics Covid-19 Diagnostic Introduction
11.10.4 BioFire Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023)
11.10.5 BioFire Diagnostics Recent Development
11.11 bioMérieux
11.11.1 bioMérieux Company Detail
11.11.2 bioMérieux Business Overview
11.11.3 bioMérieux Covid-19 Diagnostic Introduction
11.11.4 bioMérieux Revenue in Covid-19 Diagnostic Business (2018-2023)
11.11.5 bioMérieux Recent Development
11.12 Bio-Rad Laboratories
11.12.1 Bio-Rad Laboratories Company Detail
11.12.2 Bio-Rad Laboratories Business Overview
11.12.3 Bio-Rad Laboratories Covid-19 Diagnostic Introduction
11.12.4 Bio-Rad Laboratories Revenue in Covid-19 Diagnostic Business (2018-2023)
11.12.5 Bio-Rad Laboratories Recent Development
11.13 Bosch Healthcare Solutions GmbH
11.13.1 Bosch Healthcare Solutions GmbH Company Detail
11.13.2 Bosch Healthcare Solutions GmbH Business Overview
11.13.3 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Introduction
11.13.4 Bosch Healthcare Solutions GmbH Revenue in Covid-19 Diagnostic Business (2018-2023)
11.13.5 Bosch Healthcare Solutions GmbH Recent Development
11.14 Cepheid
11.14.1 Cepheid Company Detail
11.14.2 Cepheid Business Overview
11.14.3 Cepheid Covid-19 Diagnostic Introduction
11.14.4 Cepheid Revenue in Covid-19 Diagnostic Business (2018-2023)
11.14.5 Cepheid Recent Development
11.15 Co-Diagnostics
11.15.1 Co-Diagnostics Company Detail
11.15.2 Co-Diagnostics Business Overview
11.15.3 Co-Diagnostics Covid-19 Diagnostic Introduction
11.15.4 Co-Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023)
11.15.5 Co-Diagnostics Recent Development
11.16 Cue Health
11.16.1 Cue Health Company Detail
11.16.2 Cue Health Business Overview
11.16.3 Cue Health Covid-19 Diagnostic Introduction
11.16.4 Cue Health Revenue in Covid-19 Diagnostic Business (2018-2023)
11.16.5 Cue Health Recent Development
11.17 Curetis
11.17.1 Curetis Company Detail
11.17.2 Curetis Business Overview
11.17.3 Curetis Covid-19 Diagnostic Introduction
11.17.4 Curetis Revenue in Covid-19 Diagnostic Business (2018-2023)
11.17.5 Curetis Recent Development
11.18 Diagenode Diagnostics
11.18.1 Diagenode Diagnostics Company Detail
11.18.2 Diagenode Diagnostics Business Overview
11.18.3 Diagenode Diagnostics Covid-19 Diagnostic Introduction
11.18.4 Diagenode Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023)
11.18.5 Diagenode Diagnostics Recent Development
11.19 Diascopic
11.19.1 Diascopic Company Detail
11.19.2 Diascopic Business Overview
11.19.3 Diascopic Covid-19 Diagnostic Introduction
11.19.4 Diascopic Revenue in Covid-19 Diagnostic Business (2018-2023)
11.19.5 Diascopic Recent Development
11.20 Diasorin
11.20.1 Diasorin Company Detail
11.20.2 Diasorin Business Overview
11.20.3 Diasorin Covid-19 Diagnostic Introduction
11.20.4 Diasorin Revenue in Covid-19 Diagnostic Business (2018-2023)
11.20.5 Diasorin Recent Development
11.21 Expedeon
11.21.1 Expedeon Company Detail
11.21.2 Expedeon Business Overview
11.21.3 Expedeon Covid-19 Diagnostic Introduction
11.21.4 Expedeon Revenue in Covid-19 Diagnostic Business (2018-2023)
11.21.5 Expedeon Recent Development
11.22 Fusion Genomics.
11.22.1 Fusion Genomics. Company Detail
11.22.2 Fusion Genomics. Business Overview
11.22.3 Fusion Genomics. Covid-19 Diagnostic Introduction
11.22.4 Fusion Genomics. Revenue in Covid-19 Diagnostic Business (2018-2023)
11.22.5 Fusion Genomics. Recent Development
11.23 GenePOC Diagnostics
11.23.1 GenePOC Diagnostics Company Detail
11.23.2 GenePOC Diagnostics Business Overview
11.23.3 GenePOC Diagnostics Covid-19 Diagnostic Introduction
11.23.4 GenePOC Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023)
11.23.5 GenePOC Diagnostics Recent Development
11.24 GenMark Dx
11.24.1 GenMark Dx Company Detail
11.24.2 GenMark Dx Business Overview
11.24.3 GenMark Dx Covid-19 Diagnostic Introduction
11.24.4 GenMark Dx Revenue in Covid-19 Diagnostic Business (2018-2023)
11.24.5 GenMark Dx Recent Development
11.25 Hologic
11.25.1 Hologic Company Detail
11.25.2 Hologic Business Overview
11.25.3 Hologic Covid-19 Diagnostic Introduction
11.25.4 Hologic Revenue in Covid-19 Diagnostic Business (2018-2023)
11.25.5 Hologic Recent Development
11.26 Immunexpress
11.26.1 Immunexpress Company Detail
11.26.2 Immunexpress Business Overview
11.26.3 Immunexpress Covid-19 Diagnostic Introduction
11.26.4 Immunexpress Revenue in Covid-19 Diagnostic Business (2018-2023)
11.26.5 Immunexpress Recent Development
11.27 Inflammatix
11.27.1 Inflammatix Company Detail
11.27.2 Inflammatix Business Overview
11.27.3 Inflammatix Covid-19 Diagnostic Introduction
11.27.4 Inflammatix Revenue in Covid-19 Diagnostic Business (2018-2023)
11.27.5 Inflammatix Recent Development
11.28 Invetech
11.28.1 Invetech Company Detail
11.28.2 Invetech Business Overview
11.28.3 Invetech Covid-19 Diagnostic Introduction
11.28.4 Invetech Revenue in Covid-19 Diagnostic Business (2018-2023)
11.28.5 Invetech Recent Development
11.29 Janssen Diagnostics
11.29.1 Janssen Diagnostics Company Detail
11.29.2 Janssen Diagnostics Business Overview
11.29.3 Janssen Diagnostics Covid-19 Diagnostic Introduction
11.29.4 Janssen Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023)
11.29.5 Janssen Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Covid-19 Diagnostic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Immunoassay
Table 3. Key Players of Genomic and WGS Role
Table 4. Key Players of rRT-PCR
Table 5. Global Covid-19 Diagnostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Covid-19 Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Covid-19 Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Covid-19 Diagnostic Market Share by Region (2018-2023)
Table 9. Global Covid-19 Diagnostic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Covid-19 Diagnostic Market Share by Region (2024-2033)
Table 11. Covid-19 Diagnostic Market Trends
Table 12. Covid-19 Diagnostic Market Drivers
Table 13. Covid-19 Diagnostic Market Challenges
Table 14. Covid-19 Diagnostic Market Restraints
Table 15. Global Covid-19 Diagnostic Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Covid-19 Diagnostic Market Share by Players (2018-2023)
Table 17. Global Top Covid-19 Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Diagnostic as of 2022)
Table 18. Ranking of Global Top Covid-19 Diagnostic Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Covid-19 Diagnostic Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Covid-19 Diagnostic Product Solution and Service
Table 22. Date of Enter into Covid-19 Diagnostic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Covid-19 Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Covid-19 Diagnostic Revenue Market Share by Type (2018-2023)
Table 26. Global Covid-19 Diagnostic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Covid-19 Diagnostic Revenue Market Share by Type (2024-2033)
Table 28. Global Covid-19 Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Covid-19 Diagnostic Revenue Market Share by Application (2018-2023)
Table 30. Global Covid-19 Diagnostic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Covid-19 Diagnostic Revenue Market Share by Application (2024-2033)
Table 32. North America Covid-19 Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Covid-19 Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Covid-19 Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Covid-19 Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Covid-19 Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Covid-19 Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Covid-19 Diagnostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Covid-19 Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Covid-19 Diagnostic Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Covid-19 Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Covid-19 Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Covid-19 Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Covid-19 Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Covid-19 Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Covid-19 Diagnostic Market Size by Country (2024-2033) & (US$ Million)
Table 47. Abbott Diagnostics Company Detail
Table 48. Abbott Diagnostics Business Overview
Table 49. Abbott Diagnostics Covid-19 Diagnostic Product
Table 50. Abbott Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 51. Abbott Diagnostics Recent Development
Table 52. Accelerate Diagnostics Company Detail
Table 53. Accelerate Diagnostics Business Overview
Table 54. Accelerate Diagnostics Covid-19 Diagnostic Product
Table 55. Accelerate Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 56. Accelerate Diagnostics Recent Development
Table 57. Ador Diagnostics Company Detail
Table 58. Ador Diagnostics Business Overview
Table 59. Ador Diagnostics Covid-19 Diagnostic Product
Table 60. Ador Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 61. Ador Diagnostics Recent Development
Table 62. Akkoni Biosystems Company Detail
Table 63. Akkoni Biosystems Business Overview
Table 64. Akkoni Biosystems Covid-19 Diagnostic Product
Table 65. Akkoni Biosystems Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 66. Akkoni Biosystems Recent Development
Table 67. Alveo Technologies Company Detail
Table 68. Alveo Technologies Business Overview
Table 69. Alveo Technologies Covid-19 Diagnostic Product
Table 70. Alveo Technologies Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 71. Alveo Technologies Recent Development
Table 72. Applied BioCode Company Detail
Table 73. Applied BioCode Business Overview
Table 74. Applied BioCode Covid-19 Diagnostic Product
Table 75. Applied BioCode Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 76. Applied BioCode Recent Development
Table 77. Aus Diagnostics Company Detail
Table 78. Aus Diagnostics Business Overview
Table 79. Aus Diagnostics Covid-19 Diagnostic Product
Table 80. Aus Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 81. Aus Diagnostics Recent Development
Table 82. BD Diagnostics Company Detail
Table 83. BD Diagnostics Business Overview
Table 84. BD Diagnostics Covid-19 Diagnostic Product
Table 85. BD Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 86. BD Diagnostics Recent Development
Table 87. Biocartis Company Detail
Table 88. Biocartis Business Overview
Table 89. Biocartis Covid-19 Diagnostic Product
Table 90. Biocartis Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 91. Biocartis Recent Development
Table 92. BioFire Diagnostics Company Detail
Table 93. BioFire Diagnostics Business Overview
Table 94. BioFire Diagnostics Covid-19 Diagnostic Product
Table 95. BioFire Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 96. BioFire Diagnostics Recent Development
Table 97. bioMérieux Company Detail
Table 98. bioMérieux Business Overview
Table 99. bioMérieux Covid-19 Diagnostic Product
Table 100. bioMérieux Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 101. bioMérieux Recent Development
Table 102. Bio-Rad Laboratories Company Detail
Table 103. Bio-Rad Laboratories Business Overview
Table 104. Bio-Rad Laboratories Covid-19 Diagnostic Product
Table 105. Bio-Rad Laboratories Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 106. Bio-Rad Laboratories Recent Development
Table 107. Bosch Healthcare Solutions GmbH Company Detail
Table 108. Bosch Healthcare Solutions GmbH Business Overview
Table 109. Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Product
Table 110. Bosch Healthcare Solutions GmbH Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 111. Bosch Healthcare Solutions GmbH Recent Development
Table 112. Cepheid Company Detail
Table 113. Cepheid Business Overview
Table 114. Cepheid Covid-19 Diagnostic Product
Table 115. Cepheid Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 116. Cepheid Recent Development
Table 117. Co-Diagnostics Company Detail
Table 118. Co-Diagnostics Business Overview
Table 119. Co-Diagnostics Covid-19 Diagnostic Product
Table 120. Co-Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 121. Co-Diagnostics Recent Development
Table 122. Cue Health Company Detail
Table 123. Cue Health Business Overview
Table 124. Cue Health Covid-19 Diagnostic Product
Table 125. Cue Health Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 126. Cue Health Recent Development
Table 127. Curetis Company Detail
Table 128. Curetis Business Overview
Table 129. Curetis Covid-19 Diagnostic Product
Table 130. Curetis Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 131. Curetis Recent Development
Table 132. Diagenode Diagnostics Company Detail
Table 133. Diagenode Diagnostics Business Overview
Table 134. Diagenode Diagnostics Covid-19 Diagnostic Product
Table 135. Diagenode Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 136. Diagenode Diagnostics Recent Development
Table 137. Diascopic Company Detail
Table 138. Diascopic Business Overview
Table 139. Diascopic Covid-19 Diagnostic Product
Table 140. Diascopic Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 141. Diascopic Recent Development
Table 142. Diasorin Company Detail
Table 143. Diasorin Business Overview
Table 144. Diasorin Covid-19 Diagnostic Product
Table 145. Diasorin Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 146. Diasorin Recent Development
Table 147. Expedeon Company Detail
Table 148. Expedeon Business Overview
Table 149. Expedeon Covid-19 Diagnostic Product
Table 150. Expedeon Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 151. Expedeon Recent Development
Table 152. Fusion Genomics. Company Detail
Table 153. Fusion Genomics. Business Overview
Table 154. Fusion Genomics. Covid-19 Diagnostic Product
Table 155. Fusion Genomics. Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 156. Fusion Genomics. Recent Development
Table 157. GenePOC Diagnostics Company Detail
Table 158. GenePOC Diagnostics Business Overview
Table 159. GenePOC Diagnostics Covid-19 Diagnostic Product
Table 160. GenePOC Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 161. GenePOC Diagnostics Recent Development
Table 162. GenMark Dx Company Detail
Table 163. GenMark Dx Business Overview
Table 164. GenMark Dx Covid-19 Diagnostic Product
Table 165. GenMark Dx Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 166. GenMark Dx Recent Development
Table 167. Hologic Company Detail
Table 168. Hologic Business Overview
Table 169. Hologic Covid-19 Diagnostic Product
Table 170. Hologic Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 171. Hologic Recent Development
Table 172. Immunexpress Company Detail
Table 173. Immunexpress Business Overview
Table 174. Immunexpress Covid-19 Diagnostic Product
Table 175. Immunexpress Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 176. Immunexpress Recent Development
Table 177. Inflammatix Company Detail
Table 178. Inflammatix Business Overview
Table 179. Inflammatix Covid-19 Diagnostic Product
Table 180. Inflammatix Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 181. Inflammatix Recent Development
Table 182. Invetech Company Detail
Table 183. Invetech Business Overview
Table 184. Invetech Covid-19 Diagnostic Product
Table 185. Invetech Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 186. Invetech Recent Development
Table 187. Janssen Diagnostics Company Detail
Table 188. Janssen Diagnostics Business Overview
Table 189. Janssen Diagnostics Covid-19 Diagnostic Product
Table 190. Janssen Diagnostics Revenue in Covid-19 Diagnostic Business (2018-2023) & (US$ Million)
Table 191. Janssen Diagnostics Recent Development
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Diagnostic Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Covid-19 Diagnostic Market Share by Type: 2022 VS 2033
Figure 3. Immunoassay Features
Figure 4. Genomic and WGS Role Features
Figure 5. rRT-PCR Features
Figure 6. Global Covid-19 Diagnostic Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Covid-19 Diagnostic Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Laboratory Case Studies
Figure 10. Covid-19 Diagnostic Report Years Considered
Figure 11. Global Covid-19 Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Covid-19 Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Covid-19 Diagnostic Market Share by Region: 2022 VS 2033
Figure 14. Global Covid-19 Diagnostic Market Share by Players in 2022
Figure 15. Global Top Covid-19 Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Diagnostic as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Covid-19 Diagnostic Revenue in 2022
Figure 17. North America Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Covid-19 Diagnostic Market Share by Country (2018-2033)
Figure 19. United States Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Covid-19 Diagnostic Market Share by Country (2018-2033)
Figure 23. Germany Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Covid-19 Diagnostic Market Share by Region (2018-2033)
Figure 31. China Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Covid-19 Diagnostic Market Share by Country (2018-2033)
Figure 39. Mexico Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Covid-19 Diagnostic Market Share by Country (2018-2033)
Figure 43. Turkey Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Covid-19 Diagnostic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Abbott Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 46. Accelerate Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 47. Ador Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 48. Akkoni Biosystems Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 49. Alveo Technologies Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 50. Applied BioCode Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 51. Aus Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 52. BD Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 53. Biocartis Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 54. BioFire Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 55. bioMérieux Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 57. Bosch Healthcare Solutions GmbH Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 58. Cepheid Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 59. Co-Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 60. Cue Health Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 61. Curetis Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 62. Diagenode Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 63. Diascopic Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 64. Diasorin Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 65. Expedeon Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 66. Fusion Genomics. Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 67. GenePOC Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 68. GenMark Dx Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 69. Hologic Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 70. Immunexpress Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 71. Inflammatix Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 72. Invetech Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 73. Janssen Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed